The clinical relevance of NER deficiency is supported by studies demonstrating that XPC-KO mice exhibit 2.0-fold increased susceptibility to CS-carcinogen–driven lung adenocarcinomas compared with WT controls (11). This evidence concerns the gene XPC and lung adenocarcinoma.